Contact — Avalyra 26

Contact us.

Questions?

The Avalyra biophotonic platform is currently under development and has not been reviewed or approved by the U.S. Food and Drug Administration. All content on this site reflects the company's development goals pending successful clinical validation and regulatory clearance. Not available for sale.